uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation
Show others and affiliations
2011 (English)In: International Journal of Cancer, ISSN 0020-7136, E-ISSN 1097-0215, Vol. 129, no 6, 1485-1492 p.Article in journal (Refereed) Published
Abstract [en]

Most population-based studies studied the association between inflammation and prostate cancer (PCa) by assessing C-reactive protein (CRP). Since these findings have shown inconsistent results, we aimed to also study different markers that have been commonly taken as indications of inflammation.A cohort based on four groups of men (n=34,891), according to age at cohort entry (45, 55, 65, and 75 years), with measurements of glucose, triglycerides, total cholesterol, haptoglobin, albumin, hemoglobin, and leukocytes were selected from the Apolipoprotein MOrtality RISk (AMORIS) database. 17,937 had measurements of non-high-sensitivity CRP. Multivariate Cox proportional hazard models were used to analyze associations between inflammatory markers and PCa.A total of 49 out of 12,063 men developed PCa in the age 45 group, while 207 out of 9,940, 472 out of 8,266, and 276 out of 3,618 were diagnosed in the age 55, 65, and age 75 groups, respectively. Mean follow-up time was 7.5 years (SD: 3.9). No markers showed an association with PCa risk, nor was there a trend by quartiles or an indication for different PCa risks by strata of hypercholesterolemia, hyperglycemia, and hypertriglyceridemia status.The studied markers were not found to be associated with PCa risk. These null-findings might be due to methodological issues, however it is unlikely that strong and long-lasting associations between inflammation and PCa risk were missed as this was a large database with long follow-up. This indicates need for international consensus on appropriate inflammatory markers in the context of cancer that may be practically applied in large studies.

Place, publisher, year, edition, pages
2011. Vol. 129, no 6, 1485-1492 p.
Keyword [en]
prostate cancer, albumin, hemoglobin, haptoglobin, leukocytes, c-reactive protein
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-141120DOI: 10.1002/ijc.25773ISI: 000293245800025PubMedID: 21080438OAI: oai:DiVA.org:uu-141120DiVA: diva2:385042
Available from: 2011-01-11 Created: 2011-01-11 Last updated: 2015-07-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Holmberg, Lars
By organisation
Endocrine Surgery
In the same journal
International Journal of Cancer
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 173 hits
ReferencesLink to record
Permanent link

Direct link